| Ticker Details |
|
Biodesix, Inc. Common Stock
|
| IPO Date: |
November 1, 2020 |
| Sector: |
Healthcare |
| Industry: |
Healthcare Providers and Services |
| Market Cap: |
$255.55M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.28 | 5.19%
|
| Avg Daily Range (30 D): |
$0.73 | 3.29%
|
| Avg Daily Range (90 D): |
$0.68 | 4.06%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.69M |
| Avg Daily Volume (30 D): |
.06M |
| Avg Daily Volume (90 D): |
.06M |
| Trade Size |
| Avg Trade Size (Sh.): |
340 |
| Avg Trade Size (Sh.) (30 D): |
59 |
| Avg Trade Size (Sh.) (90 D): |
67 |
| Institutional Trades |
| Total Institutional Trades: |
43 |
| Avg Institutional Trade: |
$1.75M |
| Avg Institutional Trade (30 D): |
$.57M |
| Avg Institutional Trade (90 D): |
$1.39M |
| Avg Institutional Trade Volume: |
.05M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.72M |
| Avg Closing Trade (30 D): |
$.57M |
| Avg Closing Trade (90 D): |
$.84M |
| Avg Closing Volume: |
25.62K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$-3.1
|
$-.71
|
$-.81
|
|
Diluted EPS
|
$-3.1
|
$-.71
|
$-.81
|
|
Revenue
|
$102.94M
|
$26.86M
|
$25.56M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-27.76M
|
$-7.27M
|
$-7.79M
|
|
Operating Income / Loss
|
$-20.61M
|
$-5.39M
|
$-6.2M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$9.27M
|
$4.42M
|
$6.59M
|
|
PE Ratio
|
|
|
|
|
|
|